Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05704803 · ClinicalTrials.gov registry record · NA
COVID-19 Molecular OTC At Home Test
A NA study, sponsored by 3EO Health.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT05704803: Completed NA study, sponsored by 3EO Health.
NCT05704803 is a NA study that has completed, run by 3EO Health. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05704803, a NA study, has completed, sponsored by 3EO Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the a molecular, OTC/At-Home COVID-19 Test in individuals presenting at a medical facility. In eligible subjects, nasal samples will be collected for use with the at-home molecular COVID-19 Test, which will be compared to the Zymo® rRT-PCR test results obtained via samples specified by the sponsor (e.g., AN \[anterior nares\] swab) to determine accuracy of the at-home/OTC molecular COVID-19 Test in detecting COVID-19 in participants.
Interventions
- DIAGNOSTIC_TEST Diagnostic Test: IN Vitro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05704803
The ClinicalTrials.gov registry entry for NCT05704803 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The listed sponsor is 3EO Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Test: IN Vitro is the first listed.
NCT05704803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05704803 about?
NCT05704803 is a clinical study titled "COVID-19 Molecular OTC At Home Test". The objective of this study is to evaluate the a molecular, OTC/At-Home COVID-19 Test in individuals presenting at a medical facility. In eligible subjects, nasal samples will be collected for use with the at-home molecular COVID-19 Test, which will be compared to the Zymo® rRT-PCR test results obta...
What is the current status of trial NCT05704803?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2022-04-11. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05704803?
The interventions under investigation include: Diagnostic Test: IN Vitro (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05704803?
This trial is sponsored by 3EO Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.